Moderna Backs Off COVID Vaccine Patent In Dispute With NIH
By Ryan Davis · December 19, 2021, 5:26 PM EST
Moderna announced on Friday that it has delayed pursuing a patent on its COVID-19 vaccine while it disputes the National Institutes of Health's contention that the agency's scientists should be added...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login